1,132
Participants
Start Date
April 3, 2017
Primary Completion Date
July 21, 2020
Study Completion Date
July 21, 2020
ferric carboxymaltose
FCM will be administered as an undiluted bolus injection. The study treatment dose (mL) to be administered will be determined by the patient's body weight and haemoglobin (Hb) value at the respective visits where study treatment will be administered
Normal saline 0.9%
Normal saline will be administered as a bolus injection.
Hospital Universitario Austral, Buenos Aires
The Baruch Pade Medical Center, Tiberias
University of Murcia, Murcia
Hadassah Ein Kerem University Medical Center, Jerusalem
National Heart Centre of Singapore Pte, Singapore
InCor -Instituto do Coração HCFMUSP, São Paulo
Clinical Hospital Center Rijeka, Rijeka
Spedali Civilia di Brescia, Brescia
Vasculair Onderzoek Centrum, Hoorn
Kings College Hospital NHS Foundation, London
Aleksandre Aladashvili Clinic LLC, Tbilisi
American University of Beirut Medical Center, Beirut
Clinical Military Hospital, Wroclaw
Emergency Clinical Hospital, Bucharest
Skane University Hospital, Malmo
The M.D. Strazhesko Institute of Cardiology, Kyiv
Collaborators (1)
Worldwide Clinical Trials
OTHER
Cytel Inc.
INDUSTRY
Vifor (International) Inc.
INDUSTRY